Ligand validation:3ABS

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3ABS_GOL_A_2001	60%	88%	0.163	0.949	0.4	0.26	-	-	0	0	100%	1
3ABS_GOL_A_2002	59%	82%	0.134	0.915	0.37	0.43	-	-	0	0	100%	1
3ABS_GOL_A_2004	55%	90%	0.133	0.902	0.38	0.22	-	-	0	0	100%	1
3ABS_GOL_C_2003	52%	90%	0.172	0.931	0.41	0.19	-	-	0	0	100%	1
3ABS_GOL_A_2005	45%	85%	0.189	0.923	0.35	0.4	-	-	1	0	100%	1
3ABS_GOL_C_2006	16%	89%	0.247	0.813	0.38	0.25	-	-	0	0	100%	1
7XRM_GOL_A_503	65%	46%	0.153	0.954	0.96	1.11	-	1	2	0	100%	1
2YOQ_GOL_A_1196	100%	35%	0.024	0.996	0.38	2.12	-	2	0	0	100%	1
4KFD_GOL_D_806	100%	57%	0.024	0.995	0.41	1.21	-	-	0	0	100%	1
4KFE_GOL_E_803	100%	63%	0.024	0.995	0.31	1.07	-	-	0	0	100%	1
1M5Q_GOL_W_4006	100%	0%	0.027	0.992	4.89	6.2	5	3	0	0	100%	1
2Y3G_GOL_A_1150	100%	85%	0.029	0.995	0.36	0.39	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.